Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2022 08:37 ET | Source: Unicycive Therapeutics, Inc.

Unicycive Announces Acceptance of Two Preclinical Data Sets to be Presented at the European Renal Association Congress

LOS ALTOS, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease, today...